Cargando…

Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of K(v)1.3 channels and T cell responsiveness

Memantine is approved for the treatment of advanced Alzheimer's disease (AD) and reduces glutamate-mediated neuronal excitotoxicity by antagonism of N-methyl-D-aspartate receptors. In the pathophysiology of AD immune responses deviate and infectious side effects are observed during memantine th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lowinus, Theresa, Bose, Tanima, Busse, Stefan, Busse, Mandy, Reinhold, Dirk, Schraven, Burkhart, Bommhardt, Ursula H.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288222/ https://www.ncbi.nlm.nih.gov/pubmed/27462773 http://dx.doi.org/10.18632/oncotarget.10777

Ejemplares similares

Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K(v)1.3 potassium channels, AKT and ERK1/2 signaling
por: Lowinus, Theresa, et al.
Publicado: (2019)

NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells
por: Simma, Narasimhulu, et al.
Publicado: (2014)

Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy
por: Bommhardt, Ursula, et al.
Publicado: (2019)

VGF expression by T lymphocytes in patients with Alzheimer's disease
por: Busse, Stefan, et al.
Publicado: (2015)

Age-related increase of VGF-expression in T lymphocytes
por: Busse, Stefan, et al.
Publicado: (2014)

Type of PaperY192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection
por: Kästle, Matthias, et al.
Publicado: (2022)

Allgemeine Kenntnisse zu häufig angewandten Testverfahren in der rheumatologisch-immunologischen Diagnostik und Forschung
por: Reinhold, Dirk, et al.
Publicado: (2023)

The adapter protein ADAP is required for selected dendritic cell functions
por: Togni, Mauro, et al.
Publicado: (2012)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

miR-20a Inhibits TCR-Mediated Signaling and Cytokine Production in Human Naïve CD4(+) T Cells
por: Reddycherla, Amarendra V., et al.
Publicado: (2015)

Memantine has no effect on K(ATP) channels in pancreatic β cells
por: Imai, Ryota, et al.
Publicado: (2018)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Integrating Signals from the T-Cell Receptor and the Interleukin-2 Receptor
por: Beyer, Tilo, et al.
Publicado: (2011)

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Toxins Targeting the K(V)1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
por: Zhao, Yipeng, et al.
Publicado: (2015)

Selective targeting of transforming growth factor-beta1 into TCR/CD28 signalling plasma membrane domains silences T cell activation
por: Harder, Thomas, et al.
Publicado: (2014)

Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
por: Zarra, Julio, et al.
Publicado: (2010)

Memantine-induced Myoclonus in a Patient with Alzheimer Disease
por: Murgai, Aditya A., et al.
Publicado: (2015)

Memantine prodrug as a new agent for Alzheimer’s Disease
por: Sestito, Simona, et al.
Publicado: (2019)

A Logical Model Provides Insights into T Cell Receptor Signaling
por: Saez-Rodriguez, Julio, et al.
Publicado: (2007)

Immune Cell-Type Specific Ablation of Adapter Protein ADAP Differentially Modulates EAE
por: Rudolph, Jochen, et al.
Publicado: (2019)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
por: Thurm, Christoph, et al.
Publicado: (2022)

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
por: Parsons, Chris G., et al.
Publicado: (2013)

Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
por: Wang, Xiaochuan, et al.
Publicado: (2015)

Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
por: Koola, Maju Mathew, et al.
Publicado: (2018)

Zinc Aspartate Induces IL-16 Secretion and Apoptosis in Human T Cells
por: Reinhold, Dirk, et al.
Publicado: (2021)

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
por: Schmidt, R, et al.
Publicado: (2008)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats
por: RALLI, M., et al.
Publicado: (2014)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer’s disease in the Netherlands
por: Hoogveldt, Bart, et al.
Publicado: (2011)

Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro
por: Murakawa-Hirachi, Toru, et al.
Publicado: (2021)

The Transmembrane Adaptor Protein SIT Inhibits TCR-Mediated Signaling
por: Arndt, Börge, et al.
Publicado: (2011)

IL‐13 determines specific IgE responses and SARS‐CoV‐2 immunity after mild COVID‐19 and novel mRNA vaccination
por: Meltendorf, Stefan, et al.
Publicado: (2022)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
por: Rountree, Susan D, et al.
Publicado: (2009)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
por: Farrimond, Lucy E, et al.
Publicado: (2012)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
por: Sánchez-López, Elena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bjjabo3kh0fup6h2hjqckupp68